The global Chronic Obstructive Pulmonary Disease market is expected to reach USD 35.90 billion by 2030, at a CAGR of 8.2% during the forecast period 2022 to 2030. Airflow from the lungs is obstructed by Chronic Obstructive Pulmonary Disorder (COPD), a chronic inflammatory lung condition. Wheezing, coughing up phlegm, and trouble breathing are all signs of COPD.